Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Extension, Investigator Initiated Trial to Examine Radiographic Progression , Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis. EASIC (European Ankylosing Spondylitis Infliximab Cohort)

NCT00237419 is registered in ClinicalTrials.gov with Rheumazentrum Ruhrgebiet as lead sponsor.

NCT NCT00237419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00237419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Extension, Investigator Initiated Trial to Examine Radiographic Progression , Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis. EASIC (European Ankylosing Spondylitis Infliximab Cohort)
Lead sponsor
Rheumazentrum Ruhrgebiet
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2005
Completion date
April 30, 2011
Enrollment
149 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis